The Food and Drug Administration prepares to authorize the use of the Pfizer-BioNTech Covid-19 vaccine in teens ages 12 to 15 by the beginning of next week, the New York Times reveals, citing leaks provided by federal officials who have familiar with the agency’s plans. In this way, the US opens the vaccination campaign to millions of other Americans.
The news is highly anticipated. Plenty of families have been counting down since Pfizer announced the results of its teen study, showing that the vaccine is at least as effective in that age group as it is in adults.
Vaccinating children is also key to increasing the level of herd immunity in the population and reducing the number of hospitalizations and deaths. The authorization may already arrive at the end of this
.